Jenny has a passion for building businesses on the leading edge of new industries. After personally discovering the power of medical cannabis in 2014, Jenny dedicated herself to understanding the complexities of the fledgling cannabis industry. Jenny’s focus has been on guiding strategic decisions that create more possibility for a company, while mitigating risk and authentically contributing to building a brand.
For the past six years, Jenny has helped build two cannabis funds, and led strategy and product for Cura Cannabis (Select), now owned by Curaleaf. Currently Jenny is the Chief Strategy and Brand officer for Dalwhinnie Group, based in Aspen Colorado, and is co-founder of CannabisDNA, a human genomics and data company.